Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Summary Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins hyper-responsivity to a noxious inflammatory stimulus in the Wistar–Kyoto rat, a genetic background prone to heightened stress/affect. Pain is both a sensory and an emotional experience, and is subject to modulation by a number of factors including genetic background modulating stress/affect. The Wistar–Kyoto (WKY) rat exhibits a stress-hyper-responsive and depressive-like phenotype and increased sensitivity to noxious stimuli, compared with other rat strains. Here, we show that this genotype-dependent hyperalgesia is associated with impaired pain-related mobilisation of endocannabinoids and transcription of their synthesising enzymes in the rostral ventromedial medulla (RVM). Pharmacological blockade of the Cannabinoid1 (CB1) receptor potentiates the hyperalgesia in WKY rats, whereas inhibition of the endocannabinoid catabolising enzyme, fatty acid amide hydrolase, attenuates the hyperalgesia. The latter effect is mediated by CB1 receptors in the RVM. Together, these behavioural, neurochemical, and molecular data indicate that impaired endocannabinoid signalling in the RVM underpins hyper-responsivity to noxious stimuli in a genetic background prone to heightened stress/affect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“N-arachidonoylethanolamide (anandamide: AEA [15]) and 2-arachidonoylglycerol (2-AG [53,83]) are the 2 most extensively studied endogenous ligands for the cannabinoid receptors.”
BackgroundDetermination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“This system comprises at least 2 receptors, the Cannabinoid1 (CB1) [14,52] and CB2 [58] receptors, of which the CB1 receptor is most abundant in the brain.”
Background2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · cited 1×
“Our studies focused on the role of the endocannabinoid system in the rostral ventromedial medulla (RVM), given its key role in top– down descending modulation of pain [21,22,36,91], and evidence that CB1 receptors in the RVM [37,51] regulate nociceptive processing [50,55,84].”
BackgroundMolecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · cited 16×
“Kieran Rea a,c,1, Weredeselam M. Olango a,c,1, Bright N. Okine a,c, Manish K. Madasu a,c, Iseult C. McGuire a,c, Kathleen Coyle a,c, Brendan Harhen c, Michelle Roche b,c, David P. Finn a,c,⇑ a Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland b Physiology, School of Med…”
BackgroundInfluentialThe endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · cited 1×
“Our studies focused on the role of the endocannabinoid system in the rostral ventromedial medulla (RVM), given its key role in top– down descending modulation of pain [21,22,36,91], and evidence that CB1 receptors in the RVM [37,51] regulate nociceptive processing [50,55,84].”
BackgroundAn analgesia circuit activated by cannabinoids
Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L. (1998) · Nature · doi:10.1038/26481 · Cited by 411 · cited 3×
“Microinjection of cannabinoid compounds directly into the RVM have been shown to modulate neuronal firing in cells of the RVM under conditions of acute [50,54,55,57] and persistent [57] inflammatory pain, as determined by in vivo electrophysiological studies.”
BackgroundBlockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330 · cited 1×
“URB597 and AM251 were administered 60 minutes and 30 minutes before formalin injection, respectively, based on previous studies in our laboratory and others demonstrating their in vivo efficacy at these doses and times of administration [1,7,8,34,35,41,44,49].”
MethodBowker, R. M., Westlund, K. N., & Coulter, J. D. (1981) · Brain Research · doi:10.1016/0006-8993(81)91092-1 · Cited by 317
Cited by
Jennings, E. M., Okine, B. N., Roche, M., & Finn, D. P. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.003 · Cited by 318
Self-citationNir, R.-R., & Yarnitsky, D. (2015) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000126 · Cited by 314
Burke, N. N., Finn, D. P., McGuire, B. E., & Roche, M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23802 · Cited by 268
Self-citationThe cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 267
Self-citationCarnevali, L., Vacondio, F., Rossi, S., Callegari, S., Macchi, E., Spadoni, G., Bedini, A., Rivara, S., Mor, M., & Sgoifo, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.015 · Cited by 34
Metadata
- Authors
- Rea, K., Olango, W. M., Okine, B. N., Madasu, M. K., McGuire, I. C., Coyle, K., Harhen, B., Roche, M., & Finn, D. P.
- Venue
- Pain
- Published
- 2014-01
- Volume
- 155
- Issue
- 1
- Pages
- 69-79
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2076834233
- Cited by
- 69
- References
- 14
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli. https://app.cochat.ai/papers/10.1016/j.pain.2013.09.012
- The paper
- Rea, K., Olango, W. M., Okine, B. N., Madasu, M. K., McGuire, I. C., Coyle, K., Harhen, B., Roche, M., & Finn, D. P. (2014). Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli. Pain. https://doi.org/10.1016/j.pain.2013.09.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.